Capmatinib (Tabrecta) is a targeted therapy indicated for the treatment of metastatic non-small cell lung cancer (NSCLC) harboring a specific genetic mutation, namely the MET exon 14 skipping mutation. It has obtained marketing approval in multiple countries and regions worldwide. As a prescription-only medication with a relatively high price tag, patients often encounter challenges in purchasing channels selection, safe medication administration, and authenticity verification during the procurement process.

What Are the Purchase Channels for Capmatinib (Tabrecta)?

Overseas Purchase

Patients may opt to consult and purchase the medication at hospital pharmacies or licensed retail pharmacies in countries/regions where capmatinib has been approved for marketing.

Given that drug prices are subject to factors such as regional variations and exchange rate fluctuations, patients are advised to conduct adequate budget planning prior to purchase.

Purchase via Medical Service Providers

Patients can seek consultation with domestic overseas medical service institutions that have established partnerships with international pharmacies or pharmaceutical manufacturers.

These institutions typically offer legitimate import channels, along with professional consulting services and guidance.

Key Considerations for Purchasing Capmatinib (Tabrecta)

Strict Adherence to Prescriptions and Medical Advice

Capmatinib is available only with a valid physician’s prescription. The dosage or administration regimen must not be altered without medical supervision.

Prior to initiation of treatment, patients should thoroughly understand the drug’s indications, contraindications, and potential adverse reactions. Regular monitoring of liver function and pancreatic enzymes is also recommended.

Verification of Drug Version and Packaging

Capmatinib products marketed in different countries/regions may exhibit variations in packaging, labeling inserts, or accompanying materials.

Upon purchase, verify that the medication is the original product manufactured by Novartis Pharmaceuticals. Ensure the packaging is intact, the labeling is legible, and an official package insert is enclosed.

Attention to Storage and Transportation Conditions

Capmatinib must be stored at a temperature between 20°C and 25°C, protected from moisture and light exposure.

When purchasing, confirm that the medication has been maintained under appropriate temperature-controlled conditions during transportation. This is particularly crucial for mail-order or delivery services—always select providers equipped with cold chain logistics capabilities.

How to Verify the Authenticity of Capmatinib (Tabrecta)?

Inspection of Outer Packaging and Labeling

The outer packaging of genuine capmatinib should feature clear printing, uniform coloration, and be free of typographical errors or blurring.

The bottle label must include essential details: drug name, dosage strength (e.g., 150 mg or 200 mg), batch number, expiration date, manufacturer (Novartis), and storage requirements.

The bottle cap should be equipped with a sealed anti-counterfeiting design.

Examination of Tablet Appearance

Capmatinib tablets are oval-shaped, film-coated tablets. The 150 mg strength appears pale orange-brown, while the 200 mg strength is yellow. All tablets have beveled edges and are not scored.

One side of the tablet is engraved with “DU” (for 150 mg) or “LO” (for 200 mg), and the opposite side is marked with “NVR”.

Exercise caution if the tablets show abnormal coloration, misshapen features, indistinct engravings, or signs of damage.

Traceability of Batch Number and Origin

Using the batch number printed on the bottle, patients can contact the pharmaceutical manufacturer’s customer service or official verification channels to trace the drug’s distribution pathway and confirm its authenticity.

Legitimate pharmaceutical products should be accompanied by complete distribution records.